Expertise in
38
conditions

Dr. Eric C. Mueller

Rheumatology
Arthritis Northwest PLLC
105 W 8th Ave Ste 6080, 
Spokane, WA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
38
conditions
Arthritis Northwest PLLC
105 W 8th Ave Ste 6080, 
Spokane, WA 

Overview

Eric Mueller is a Rheumatologist practicing medicine in Spokane, Washington.

Dr. Mueller is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Axial Spondyloarthritis (AxSpA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Psoriatic Arthritis.

He is actively involved in clinical research, participating in 10 clinical trials. Dr. Mueller is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in WA

Hospital Affiliations

Coulee Medical Center
Tacoma General Allenmore Hospital
Kootenai Health
Prov Sacred Hrt Med Ctr & Childs Hosp.
Pullman Regional Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Arthritis Northwest PLLC
105 W 8th Ave Ste 6080, Spokane, WA 99204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Diagnostic test
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required
105 West 8th Avenue, Suite 6080W, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Howard Kenney is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Kenney is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Synovitis, Psoriatic Arthritis, Orchiectomy, and Craniectomy.

Expertise in
34
conditions
Dr. Michael C. Coan
Rheumatology
Expertise in
34
conditions
Dr. Michael C. Coan
Rheumatology
Referral may be required
Before you request

Arthritis Northwest PLLC

105 W 8th Ave Ste 6080, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Coan is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Coan is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), and Rheumatoid Lung Disease. Dr. Coan is currently accepting new patients.

Expertise in
37
conditions
Expertise in
37
conditions
Referral may be required
Before you request

Inland NW ASC

105 W 8th Ave Ste 6080, 
Spokane, WA 
 (0.1 miles away)
509-838-6500
Languages Spoken:
English, German, Spanish, Swedish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Butler is a Rheumatologist practicing medicine in Spokane, Washington. Dr. Butler is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Raynaud Phenomenon. Dr. Butler is currently accepting new patients.

Frequently Asked Questions about Dr. Eric C. Mueller

How do I make an appointment with Dr. Eric C. Mueller?

You can book an appointment with Dr. Eric C. Mueller by calling their office at 509-838-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eric C. Mueller a top-rated expert for Axial Spondyloarthritis (AxSpA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eric C. Mueller is classified as an Distinguished expert for Axial Spondyloarthritis (AxSpA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eric C. Mueller specialize in?

While Dr. Eric C. Mueller is a Rheumatology, they have specific expertise in Axial Spondyloarthritis (AxSpA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Eric C. Mueller accept my insurance?

Dr. Eric C. Mueller accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 509-838-6500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mueller's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 28 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile